Implementing and Scaling Up a Team-based Care Strategy for Hypertension Control in Colombia and Jamaica
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Tulane University
- Enrollment
- 1280
- Locations
- 2
- Primary Endpoint
- Net difference in mean change of systolic blood pressure
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
The CATCH cluster randomized trial will test the implementation and effectiveness outcomes of implementing and scaling up a team-based care strategy for blood pressure control in Colombia and Jamaica.
Detailed Description
The CATCH Study includes a two-year UG3 Planning Phase and a four-year UH3 Implementation Phase. In the UH3 Implementation Phase, we will first conduct a cluster randomized implementation trial to test the effectiveness and implementation of a team-based care strategy for hypertension control among patients with hypertension in 40 clinics from Colombia and Jamaica (20 in each country). Twenty clinics will be randomized to the team-based care intervention and 20 to provider training intervention. A total of 1,680 patients (42 per clinic) with uncontrolled hypertension will be recruited into the study and followed for 18 months for effectiveness and implementation outcomes. A post-intervention study visit will take place 6 months after the end of the 18-month intervention to evaluate the sustainability of the implementation strategies. We will subsequently conduct a pre- and post- scale-up comparison study to implement the team-based care strategy in all remaining public primary care clinics that provide chronic disease management in Jamaica and primary care clinics in the seven participating departments in Colombia. A pre- and post- scale-up comparison design will be used to assess barriers and implementation outcomes before and 12 months after the scale-up intervention at the clinic, primary care physician, nurse/pharmacist, and community health worker (CHW) levels.
Investigators
Jiang He, MD, PhD
Professor and Chair
Tulane University
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Net difference in mean change of systolic blood pressure
Time Frame: 18 months
Differences in mean change of systolic BP from baseline to 18 months between intervention and control groups
Secondary Outcomes
- Difference in blood pressure control (<130/80 mm Hg)(18 months)
- Side effects(18 months)
- Health-related quality of life(18 months)
- Net difference in mean change of diastolic blood pressure(18 months)
- Cost-effectiveness(18 months)